UGEL, Stefano
 Distribuzione geografica
Continente #
EU - Europa 3.139
NA - Nord America 3.110
AS - Asia 2.194
SA - Sud America 354
AF - Africa 43
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.856
Nazione #
US - Stati Uniti d'America 3.061
SG - Singapore 802
GB - Regno Unito 786
CN - Cina 740
IT - Italia 715
DE - Germania 342
BR - Brasile 309
HK - Hong Kong 301
RU - Federazione Russa 242
FI - Finlandia 217
IE - Irlanda 203
FR - Francia 196
SE - Svezia 190
VN - Vietnam 109
NL - Olanda 80
KR - Corea 72
ID - Indonesia 44
UA - Ucraina 43
AT - Austria 31
BE - Belgio 29
CA - Canada 22
JP - Giappone 21
IN - India 19
TR - Turchia 19
BD - Bangladesh 18
TG - Togo 18
CZ - Repubblica Ceca 13
ES - Italia 13
MX - Messico 12
AR - Argentina 11
AU - Australia 11
ZA - Sudafrica 11
CO - Colombia 10
IQ - Iraq 8
EC - Ecuador 7
PL - Polonia 6
PK - Pakistan 5
PY - Paraguay 5
SA - Arabia Saudita 5
CH - Svizzera 4
IL - Israele 4
VE - Venezuela 4
CL - Cile 3
CR - Costa Rica 3
IR - Iran 3
LT - Lituania 3
MA - Marocco 3
NZ - Nuova Zelanda 3
PA - Panama 3
PE - Perù 3
RO - Romania 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AZ - Azerbaigian 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
EG - Egitto 2
ET - Etiopia 2
EU - Europa 2
JM - Giamaica 2
JO - Giordania 2
KE - Kenya 2
KG - Kirghizistan 2
LU - Lussemburgo 2
MY - Malesia 2
OM - Oman 2
PS - Palestinian Territory 2
SV - El Salvador 2
AD - Andorra 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BJ - Benin 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
GE - Georgia 1
GM - Gambi 1
HN - Honduras 1
HR - Croazia 1
IS - Islanda 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MK - Macedonia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
PH - Filippine 1
PT - Portogallo 1
SI - Slovenia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 8.856
Città #
Southend 724
Chandler 408
Dallas 397
Verona 376
Singapore 336
Hong Kong 292
Ashburn 241
Munich 203
Dublin 195
Jacksonville 186
Woodbridge 159
Beijing 156
Ann Arbor 141
New York 130
Helsinki 101
Redmond 84
Houston 83
Los Angeles 68
Lawrence 61
Princeton 61
Jinan 58
Wilmington 58
Shenyang 51
Nanjing 42
Jakarta 40
The Dalles 40
Redondo Beach 38
Turku 36
Dong Ket 34
Milan 32
Buffalo 30
Brussels 29
Columbus 29
São Paulo 26
Zhengzhou 24
Hebei 22
Lappeenranta 22
Amsterdam 20
Nanchang 20
Ningbo 20
Tianjin 20
Council Bluffs 19
Brooklyn 18
Haikou 18
Lomé 18
Washington 18
Frankfurt am Main 17
Hangzhou 17
Nuremberg 17
Redwood City 17
Santa Clara 17
Sindelfingen 17
Vienna 17
Tokyo 16
Changsha 15
Chicago 15
Guangzhou 15
Seoul 15
Hanoi 14
Jiaxing 14
Seattle 14
San Francisco 13
Boydton 12
Phoenix 12
Boardman 11
Norwalk 11
Padova 11
Taiyuan 11
Atlanta 10
London 10
Moscow 10
Sant'Ambrogio di Valpolicella 10
Taizhou 10
San Giovanni Lupatoto 9
Belo Horizonte 8
Brasília 8
Cagliari 8
Cambridge 8
Dearborn 8
Rio de Janeiro 8
Stockholm 8
Brno 7
Chions 7
Fuzhou 7
Ho Chi Minh City 7
Kent 7
Paris 7
St Louis 7
Bologna 6
Boston 6
Fortaleza 6
Johannesburg 6
Jyväskylä 6
Madrid 6
Mexico City 6
Modena 6
Montreal 6
St Petersburg 6
Toronto 6
Auburn Hills 5
Totale 5.737
Nome #
IFN-gamma- Mediated Upmodulation of MHC Class I Expression Activates Tumor-Specific Immune Response in a Mouse Model of Prostate Cancer 222
Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients 218
MAP Kinase inhibition reshapes tumour microenvironment of mouse pancreatic cancer by depleting anti-inflammatory macrophages 206
IFN-gamma- Mediated Upmodulation of MHC Class I Expression Associated to a B7-1-Expressing Tumor Cell Vaccine Activates Tumor-Specific Immune Response in a Mouse Model of Prostate Cancer. 203
Identification of microRNAs implicated in the late differentiation stages of normal B cells suggests a central role for miRNA targets ZEB1 and TP53 192
CD66b-CD64dimCD115- cells in the human bone marrow represent neutrophil-committed progenitors 178
Autologous cellular vaccine overcomes cancer immunoediting in a mouse model of myeloma 170
Autoimmune B-cell lymphopenia after successful adoptive therapy with telomerase-specific T lymphocytes. 164
Unraveling the role of lymph node metastasis in PDAC and dCCA progression 159
Feasibility of telomerase-specific adoptive T-cell therapy for B-cell chronic lymphocytic leukemia and solid malignancies 155
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3 154
Hyperthermic treatment at 56 °C induces tumour-specific immune protection in a mouse model of prostate cancer in both prophylactic and therapeutic immunization regimens 149
Deciphering the state of immune silence in fatal COVID-19 patients 147
Baricitinib restrains the immune dysregulation in patients with severe COVID-19 146
IFN-gamma-mediated upmodulation of MHC class I expression activates tumor-specific immune response in a mouse model of prostate cancer 145
Effective control of acute myeloid leukaemia and acute lymphoblastic leukaemia progression by telomerase specific adoptive T-cell therapy 143
Immunoevolution of mouse pancreatic organoid isografts from preinvasive to metastatic disease 143
Induction of immunosuppressive functions and NF-κB by FLIP in monocytes 130
The Emerging Immunological Role of Post-Translational Modifications by Reactive Nitrogen Species in Cancer Microenvironment 124
MDSCs in cancer: Conceiving new prognostic and therapeutic targets 124
Fatal cytokine release syndrome by an aberrant FLIP/STAT3 axis 123
Disabled homolog 2 controls pro-metastatic activity of tumor-associated macrophages 122
Organoid-Transplant Model Systems to Study the Effects of Obesity on the Pancreatic Carcinogenesis in vivo 117
Dynamics of SARS-CoV2 Infection and Multi-Drug Resistant Bacteria Superinfection in Patients With Assisted Mechanical Ventilation 117
Interrupting the nitrosative stress fuels tumor-specific cytotoxic T lymphocytes in pancreatic cancer 115
A Relay Pathway between Arginine and Tryptophan Metabolism Confers Immunosuppressive Properties on Dendritic Cells 114
Interfacing polymeric scaffolds with primary pancreatic ductal adenocarcinoma cells to develop 3D cancer models. 113
The Endless Saga of Monocyte Diversity 113
Immunomodulation after radiofrequency ablation of locally advanced pancreatic cancer by monitoring the immune response in 10 patients 111
Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages 109
Therapeutic targeting of myeloid-derived suppressor cells. 106
The immune modulatory effects of umbilical cord-derived mesenchymal stromal cells in severe COVID-19 pneumonia 106
Tumor endothelial marker 1-specific DNA vaccination targets tumor vasculature 104
Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor. 103
Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells. 103
GCN2 drives macrophage and MDSC function and immunosuppression in the tumor microenvironment 103
B-cell receptor signaling activity identifies patients with mantle cell lymphoma at higher risk of progression 102
Anti-telomerase T cells adoptive transfer 102
Discovery of highly potent benzimidazole derivatives as indoleamine 2,3-dioxygenase-1 (IDO1) inhibitors: from structure-based virtual screening to in vivo pharmacodynamic activity 102
Immune tolerance to tumor antigens occurs in a specialized environment of the spleen. 101
The Engagement Between MDSCs and Metastases: Partners in Crime 101
Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF. 101
Antibody-based delivery of interleukin-2 modulates the immunosuppressive tumor microenvironment and achieves cure in pancreatic ductal adenocarcinoma syngeneic mice 100
Axon guidance cue SEMA3A promotes the aggressive phenotype of basal-like PDAC 99
Neutralization of NET-associated human ARG1 enhances cancer immunotherapy 99
Preventive vaccination with telomerase controls tumor growth in genetically engineered and carcinogen-induced mouse models of cancer. 99
Interaction of human pancreatic ductal adenocarcinoma cells with polymeric scaffolds to develop tissue-engineered cancer models. 97
Targeting tumor vasculature: expanding the potential of DNA cancer vaccines 97
Role of arginine metabolism in immunity and immunopathology. 95
In vivo administration of artificial antigen-presenting cells activates low-avidity T cells for treatment of cancer. 94
Leukocyte infiltration in cancer creates an unfavorable environment for antitumor immune responses: a novel target for therapeutic intervention. 90
The immune regulation in cancer by the amino acid metabolizing enzymes ARG and IDO. 90
T-cell tracking using Cerenkov and radioluminescence imaging 89
Immune-guided therapy of COVID-19. 89
Characterization of Myeloid-derived Suppressor Cells in a Patient With Lung Adenocarcinoma Undergoing Durvalumab Treatment: A Case Report 86
The dark side of tumor-associated endothelial cells 85
Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade 82
Nicotinamide Phosphoribosyltransferase Acts as a Metabolic Gate for Mobilization of Myeloid-Derived Suppressor Cells 81
HS-5 and HS-27A Stromal Cell Lines to Study Bone Marrow Mesenchymal Stromal Cell-Mediated Support to Cancer Development 81
Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer 81
T Cell Cancer Therapy Requires CD40-CD40L Activation of Tumor Necrosis Factor and Inducible Nitric-Oxide-Synthase-Producing Dendritic Cells 80
Four-class tumor staging for early diagnosis and monitoring of murine pancreatic cancer using magnetic resonance and ultrasound 79
Tumor-Induced Myeloid-Derived Suppressor Cells 78
Circulating IgG4+ Plasmablast Count as a Diagnostic Tool in Autoimmune Pancreatitis 77
Expression of the membrane tetraspanin claudin 18 on cancer cells promotes T lymphocyte infiltration and antitumor immunity in pancreatic cancer 75
Characterizing the immune tumor microenvironment in ALK fusion-positive lung cancer: state-of-the-art and therapeutical implications 73
CXCR1/2 dual-inhibitor ladarixin reduces tumour burden and promotes immunotherapy response in pancreatic cancer 73
Neutrophils inhibit γδ T cell functions in the imiquimod-induced mouse model of psoriasis 73
Monocytes in the Tumor Microenvironment 73
Methods to Measure MDSC Immune Suppressive Activity In Vitro and In Vivo 72
Local ablation disrupts immune evasion in pancreatic cancer 69
Phenotypical Characterization and Isolation of Tumor-Derived Mouse Myeloid-Derived Suppressor Cells 67
Arginase 1-Based Immune Modulatory Vaccines Induce Anticancer Immunity and Synergize with Anti-PD-1 Checkpoint Blockade. 65
Identification of a Compound Inhibiting Both the Enzymatic and Nonenzymatic Functions of Indoleamine 2,3-Dioxygenase 1 64
Plasmacytoid Dendritic Cell, Slan+-Monocyte and Natural Killer Cell Counts Function as Blood Cell-Based Biomarkers for Predicting Responses to Immune Checkpoint Inhibitor Monotherapy in Non-Small Cell Lung Cancer Patients 63
Cellular collusion: cracking the code of immunosuppression and chemo resistance in PDAC 61
Prognostic impact of Interleukin-8 levels in lung cancer: A meta-analysis and a bioinformatic validation 59
Targeting tumour-reprogrammed myeloid cells: the new battleground in cancer immunotherapy 57
"Open Sesame" to the complexity of pattern recognition receptors of myeloid-derived suppressor cells in cancer 55
Moonlighting Proteins Are Important Players in Cancer Immunology 52
Breaking the Immune Complexity of the Tumor Microenvironment Using Single-Cell Technologies 50
A Complex Metabolic Network Confers Immunosuppressive Functions to Myeloid-Derived Suppressor Cells (MDSCs) within the Tumour Microenvironment 49
p140Cap inhibits β-Catenin in the breast cancer stem cell compartment instructing a protective anti-tumor immune response 48
Colorectal cancer patients-derived immunity-organoid platform unveils cancer-specific tissue markers associated with immunotherapy resistance 47
HER2 Aberrations in NSCLC: So Close Yet So Far 46
Pre-diagnostic prognostic value of leukocytes count and neutrophil-to-lymphocyte ratio in patients who develop colorectal cancer 37
Talniflumate abrogates mucin immune suppressive barrier improving efficacy of gemcitabine and nab-paclitaxel treatment in pancreatic cancer 34
Harnessing the reverse cholesterol transport pathway to favor differentiation of monocyte-derived APCs and antitumor responses 34
Tackling TNF-α in autoinflammatory disorders and autoimmune diseases: From conventional to cutting edge in biologics and RNA- based nanomedicines 33
GateMeClass: Gate Mining and Classification of cytometry data 30
Totale 9.067
Categoria #
all - tutte 36.290
article - articoli 33.435
book - libri 0
conference - conferenze 1.149
curatela - curatele 0
other - altro 1.303
patent - brevetti 0
selected - selezionate 0
volume - volumi 403
Totale 72.580


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021446 0 0 0 72 76 60 18 16 47 23 48 86
2021/2022553 38 152 37 21 18 12 17 38 49 17 41 113
2022/20231.268 72 165 105 221 102 310 23 71 130 8 38 23
2023/2024921 34 51 63 89 121 188 66 65 15 70 131 28
2024/20252.651 118 108 139 393 100 118 255 208 375 135 255 447
2025/20261.295 440 358 443 54 0 0 0 0 0 0 0 0
Totale 9.067